Emergence of Stuttering in an Attention Deficit Hyperactivity Disorder Patient Treated with Methylphenidate

References (5)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth Ed. Washington, DC: American Psychiatric Publishing, 2013.
2. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock’s synopsis of psychiatry, behavioral sciences/clinical psychiatry. Eleventh Ed. Philadelphia: Wolters Kluwer, 2015.
3. Sathya JMA, Victor SP. Types and tools available for fluency disorder - speech therapy. International Journal of Engineering and Computer Science 2015; 4:12423-12428.
4. Devroey D, Beerens G, Van De Vijver E. Methylphenidate as a treatment for stuttering: a case report. Eur Rev Med Pharmacol Sci 2012; 16(Suppl.4):66-69.
5. Bozatli L, Berberoglu KK, Ceylan C, Gorker I. Improvement of stuttering with use of methylphenidate in a child who was diagnosed with concomitant stuttering and ADHD. Anatolian Journal of Psychiatry 2016; 17(Suppl.3):71-73. (Turkish) [CrossRef] Anderson JM, Hughes JD, Rothi LJ, Crucian GP, Heilman KM. Developmental stuttering and Parkinson’s disease: the effects of levodopa treatment. J Neurol Neurosurg Psychiatry 1999; 66:776-778. [CrossRef] Wu JC, Maguire G, Riley G, Lee A, Keator D, Tang C, Fallon J, Najafi A. Increased dopamine activity associated with stuttering. Neuroreport 1997; 8:767–770. [CrossRef] Alpaslan AH, Coskun KS, Kocak U, Gorucu Y. Stuttering associated with the use of short-acting oral methylphenidate. J Clin Psychopharmacol 2015; 35:739-741. (Turkish) [CrossRef] Blood GW, Ridenour VJ, Qualls CD, Hammer CS. Co-occurring disorders in children who stutter. J Commun Disord 2003; 36:427-448. [CrossRef]